author-photo

Neil R. Cashman

University of British Columbia
Montreal Neurological Institute and Hospital
University of Toronto

271

Papers

12355

Citations

Citation Trend

Filter By

Papers (271) Sort By

Journal Conference Others

Epitope scaffolding using alpha-synuclein cyclic peptides to generate oligomer-selective antibodies for Parkinson's disease

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson’s disease models

2021
Show All
- Source
- Cite
- Save
Citations (4)
Sublethal Enteroviral Infection Exacerbates Disease Progression in an ALS Mouse Model

2021
Show All
- Source
- Cite
- Save
Citations (0)
A method for systematically ranking therapeutic drug candidates using multiple uncertain screening criteria.

2021 Statistical Methods in Medical Research
Show All
- Source
- Cite
- Save
Citations (1)
Purification and Structural Characterization of Aggregation-Prone Human TDP-43 Involved in Neurodegenerative Diseases.

2020 iScience
Show All
- Source
- Cite
- Save
Citations (8)
Tardive neurotoxicity of anticholinergic drugs: a review.

2020 Journal of Neurochemistry
Show All
- Source
- Cite
- Save
Citations (2)
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease.

2020 Neurobiology of Disease
- Steven S. Plotkin
- Neil R. Cashman
Show All
- Source
- Cite
- Save
Citations (22)
Tryptophan residues in TDP-43 and SOD1 mediate the cross-seeding and toxicity of SOD1

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Rationally designed antibodies selective for pathogenic tau aggregates: Nonhuman: Preclinical immunotherapeutic studies

2020 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (0)
TNF receptor associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)